Laser treatment for hidradenitis suppurativa (acne inversa)
Part of Infections, Skin clinical trials.
This trial tests a 1726-nm laser to reduce inflamed nodules in people with mild to moderate hidradenitis suppurativa (HS). It compares treated and untreated areas to see if the laser helps without affecting the rest of the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have hidradenitis suppurativa (HS) that a doctor has confirmed as stage I or II (Hurley scale).
- You currently have at least one red, painful bump (nodule) in a matched area on both sides of your body (like both armpits or both groins).
- You agree to avoid new HS treatments or procedures on the study areas for 6 months.
- You are willing to shave or clip hair in the treatment areas before each session.
- You can understand English, Chinese, Spanish, or Vietnamese and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine given by injection (anti-IL-17A/F antibody) combined with a laser treatment (non-ablative dot laser) for people with mild to moderate hidradenitis suppurativa (also called HS). The goal is to see if the combination is safe and works better than current options, and might help reduce pain and flare-ups.
This study compares two types of laser treatments (Nd:YAG and Alexandrite) to see which one works better for hidradenitis suppurativa, a condition that causes painful bumps under the skin. If you join, you'll receive one of these laser treatments to help reduce your symptoms.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This trial tests a new medication called CIT-013 for people with moderate to severe hidradenitis suppurativa (HS) who have not had enough relief from oral antibiotics. The goal is to see if this treatment can reduce painful bumps and abscesses.
This trial tests if low-dose radiation therapy can help people with moderate to severe hidradenitis suppurativa (HS) that hasn't gotten better with other treatments. It's for those with sores in both armpits.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.